BICB Not Involved in Allegation of Conspiracy to
Post# of 98044
Phoenix, AZ -- (March 17, 2017) – BioCube, Inc. (OTCPink: BICB) (the "Company", a technology company with a focus on environmental and technical infrastructure projects related to homeland security, renewable energy and clean technologies, announces today that neither the Company nor its management have been implicated in the recent news of allegations of a conspiracy by four persons to commit various crimes of fraud related to the common stock of the Company.
On Friday, April 14, 2017, the Justice Department issued a press release informing the public of the arrest of four persons on charges of conspiracy to commit various crimes of fraud related to the common stock of the Company. Management of the Company learned of the arrest through news reports and the press release issued by the Justice Department. Management was not aware of any alleged scheme or conspiracy being committed, nor has Management been contacted by any authorities related to the matter. . The Company, at this time, has no further information regarding the matter beyond what is public knowledge. These events, whether true or not, have caused great concern for management and likely for shareholders. It is the goal of the Company to continue to move forward with operations, including the Joint Venture with IUT Medical GmbH (“IUT”), a German corporation specializing in the research, development and manufacturing of analytic sensors and devices. If Management becomes aware of any additional information regarding this matter, they will provide a prompt update to shareholders.
About BioCube, Inc.
BioCube, Inc. is a technology company with a focus on environmental and technical infrastructure projects related to homeland security, renewable energy and clean technologies.
Forward-Looking Statements
Non-historical statements included in this press release are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the Company's future performance are subject to many factors including, but not limited to: working capital and availability of capital, implementation difficulties, impacts involving key vendors, lenders, competitors, and other risks detailed in the Company's Form 10-K for the year ended December 31, 2015, and other subsequent SEC filings. Such statements are based upon management's current beliefs and expectations subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. When used in this press release, the terms "anticipate", "believe", "estimate", "expect", "may", "should", "plan", "possible", "potential", "project", "will", and similar expressions identify forward-looking statements. There is no guarantee that the Company will enter into the agreements referenced herein, nor if we do, that successful implementation will transpire. The forward-looking statements contained herein are made as of the date hereof, and we do not undertake any obligation to update any forward-looking statements, whether as a result of future events, new information, or otherwise.
BioCube, Inc.
7320 North Dreamy Draw Drive
Suite 120
Phoenix, AZ 85020
Phone: 646-450-6194
Email: info@biocubeinc.com